Kyungdong Pharm
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
KyungdongPharm makes prescription and over-the-counter medicines supplied to patients and healthcare providers in South Korea.
It is listed on KOSDAQ, South Korea's technology and small-cap stock exchange. The company operates through a parent entity alongside several unlisted subsidiaries, giving it a consolidated group structure.
Summary is AI-generated and may contain errors · figures from DART filings
The company consolidates seven subsidiaries under its group structure, none of which are separately listed on a public exchange.
Kyungdong Pharm in five facts
What does Kyungdong Pharm do?
KyungdongPharm makes prescription and over-the-counter medicines supplied to patients and healthcare providers in South Korea.
Where is Kyungdong Pharm listed and in which sector?
Kyungdong Pharm (Korean name: 경동제약) trades under KRX code 011040 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is Kyungdong Pharm?
Its market capitalisation was US$116.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Kyungdong Pharm's latest annual revenue and operating profit?
For fiscal year 2025, Kyungdong Pharm reported revenue of US$148.1M, operating profit of US$5.8M and net income of US$6.4M, per its annual report on DART (data retrieved from DART on 2026-09-08). Revenue was up 1.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-08
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Report on securities held by executives/major shareholdersOct 21
- Report on securities held by executives/major shareholdersOct 8
- Report on large shareholdings (5% rule) (standard)Aug 31
- [Amended] Share-pledge agreement that may change the largest shareholder
Kyungdong Pharm's largest shareholder (an individual) pledged shares as loan collateral to an individual, securing up to US$11.4M.
Ownership change · Aug 27 - [Amended] Share-pledge agreement that may change the largest shareholder
Kyungdong Pharm's largest shareholder (an individual) pledged shares as loan collateral to an individual, securing up to US$13M.
Ownership change · Jul 6 - Treasury share disposal: results reportTreasury Shares · Mar 11
- [Amended] Cash/in-kind dividend decision
Kyungdong Pharm updated its declared cash dividend of US$0.20 per share, equal to about 4.9% of the recent share price.
Dividend · Mar 6 · 2 versions - Material event report (treasury share disposal)
Kyungdong Pharm disclosed a plan to sell treasury shares worth US$254K, about 0.2% of its market value.
Treasury Shares · Mar 5 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Kyungdong Pharm reported consolidated results for FY2025: revenue of US$136M (+1.2% year on year), operating profit of US$5.32M (+192.2% year on year) and net income of US$5.88M (+55.4% year on year).
Earnings · Feb 13